Symptoms may include weakness in hips, shoulders, upper arms, and legs, fatigue, irritability, and delayed motor development
Once per week injections for 4-6 weeks, then monthly maintance
Iron-dependent erythropoiesis in women with excessive menstrual blood losses and women with normal menses
MT2A simultaneously controls zinc-binding proteins by adding or removing zinc and is transcriptionally inducible by these proteins to target its promoter region, which contains numerous regulatory elements, such as the MRE
Additionally, follow-up at 31 weeks showed no difference in eGFR between the placebo and oral-semaglutide groups compared with baseline eGFR measurements, suggesting that treatment had no adverse effects on kidney function
This modification facilitates its binding to histone acetyltransferases and ultimately inhibits PGC-1s transcriptional activity (Xiong et al., 2010)